Phoenix News Desk

Point of Care Diagnostics (POC) Market Will Be Worth $18.7 Billion by 2020: Grand View Research, Inc.

Point of Care Diagnostics (POC) Market Will Be Worth $18.7 Billion by 2020: Grand View Research, Inc.

Grand View Research, Inc. – Market Research And Consulting.
Latest report published by Grand View Research suggests, Relatively lower turnaround times exhibited by point of care diagnostic tests and the introduction of technologically advanced products enabled with features such as automation and miniaturization, are two of the most significant growth drivers of the POC Diagnostics market.

The global market for point of care diagnostics is expected to reach USD 18.7 billion by 2020, according to a new study by Grand View Research, Inc. Relatively lower turnaround times exhibited by point of care diagnostic tests and the introduction of technologically advanced products enabled with features such as automation and miniaturization, are two of the most significant growth drivers of this market. Moreover, cost effectiveness associated with these tests in terms of infrastructure and staff management coupled with growing global prevalence of diabetes and cardiovascular diseases and rising market penetration rates of point of care diagnostic products in emergency departments and ICUs are expected to drive market demand over the next six years

Growing number of decentralized diagnostic facilities is a significant trend observed in this market. Rise in prevalence of diseases with high unmet medical needs in terms of early diagnosis and treatment such as stroke, sepsis, hypercoagulation and diabetes and reimbursement policies supporting decentralized tests are some of the factors responsible for this market trend.

Full research report on Global Point of Care Diagnostics (POC) Market with detailed figures and charts available at:
http://www.grandviewresearch.com/industry-analysis/point-of-care-poc-diagnostics-industry 

The hospital glucose testing market dominated the overall market in 2012, accounting for over 10% of the global revenue. Rising global prevalence of diabetes, high market penetration of handheld glucose monitoring devices and growing patient awareness levels in this segment are some of the factors attributing to its market share. Furthermore, OTC and rapid diagnostic tests and cardiac markers market are identified as two of the fastest growing segments. Rapid diagnosis enabling the timely treatment of diseases especially in the cardiovascular disease segment is one of the highest impact rendering drivers of this market.

Further Key findings from the study suggest:

  • The global point of care diagnostics market was valued at USD 13.5 billion in 2012 and is expected to grow at a CAGR of 4.2% from 2013 to 2020
  • North America dominated the overall market in 2012 at over 35%. The presence of an encouraging reimbursement framework and the introduction of CLIA (Clinical Laboratory Improvement Amendments) waivers (e.g. waiver received by the HemoCue Albumin 201 System) for point of care test products by the U.S. FDA are some of the drivers of the North America market. 
  • The Asia Pacific point of care diagnostics market on the other hand will grow at the fastest rate during the forecast period owing to the presence of high unmet medical needs coupled with rising healthcare expenditures in emerging countries such as India and China
  • The global point of care diagnostics market is dominated by key players such as Roche Diagnostics, Abbott Laboratories, Beckman Coulter Inc., Siemens Healthcare, Danaher Corporation, Becton Dickinson and Company


Get more information on Global Point of Care Diagnostics (POC) Market or request for sample of this research report at: 
http://www.grandviewresearch.com/industry-analysis/point-of-care-poc-diagnostics-industry 

For the purpose of this study, Grand View Research has segmented the global point of care diagnostics market on the basis of product, end-user and region:

Point of Care Diagnostics Product Outlook

  • Blood Gas/Electrolytes (Centralized and Decentralized)
  • Infectious Diseases
  • Hospital Glucose Testing
  • Cardiac Markers
  • Hematology
  • Coagulation
  • Primary Care Systems (Lipid Profiling and HbA1c Tests)
  • Decentralized Clinical Chemistry
  • Urinalysis
  • Drug Abuse Testing
  • Fertility
  • OTC and Rapid Diagnostic Tests


Point of Care Diagnostics End User Outlook

  • Hospitals
  • Assisted Living Healthcare Facilities
  • Laboratories
  • Home
  • Clinics
  • Others


Point of Care Diagnostics Regional Outlook

  • North America
  • Europe
  • Asia Pacific
  • RoW


View more reports of this category by Grand View Research at: 
http://www.grandviewresearch.com/industry/clinical-diagnostics 


About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information, visit – Grand View Research 

Blog – http://iamamontreal2013.com/ 

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James
Email: Send Email
Phone: 1-415-349-0058
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Website: http://www.grandviewresearch.com/industry-analysis/point-of-care-poc-diagnostics-industry